Remove 2013 Remove Doctors Remove Patients Remove Prescription
article thumbnail

Constipation Patients Are Suffering in Silence—Here’s How to Help Them

PM360

1 Yet, most patients haven’t tried prescription therapies, a discovery Phreesia Life Sciences made after surveying 6,780 adults age 18 and older who previously had been diagnosed with or treated for constipation as they checked in for their doctors’ appointments. Address Patients’ Quality of Life. Why the disconnect?

article thumbnail

The best way to lower healthcare costs

World of DTC Marketing

And despite ongoing efforts to combat it, such as the AMA’s 2013 official recognition of obesity as a disease, the problem continues to worsen. Pharma should strive to get patients off some prescription drugs because they lost weight and are eating well, but we know that’s not going to happen. percent in 2007-2008 to 39.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

Because nearly all prescriptions are now written electronically. When a patient meets predetermined triggering criteria, a brand message appears in the EHR. These digital wallboards had a smaller footprint within the doctors’ offices, but delivered the messages with much more dynamic effect.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. RxPass offers more than 50 select prescriptions at no additional cost for $5 per month.

Retail 52
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

RSV poses a particular threat to older and younger patients , and it is the single most common reason for most children being admitted to most US hospitals. Furthermore, the first vaccine may have more time to build “patient/practitioner familiarity and trust”, she says in an email to Pharmaceutical Technology.

Pharma 64